四川
分享至
摘要：当全球生物医药行业榜单更新，一款来自中国本土的原创双抗药物，打破海外药企长期垄断，稳稳拿下全球研发项目价值榜首。
特别声明：以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布，本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.
